Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-11
2006-07-11
Barts, Samuel (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S535000, C514S604000, C514S506000, C514S562000, C514S255030, C514S317000, C514S330000, C514S331000, C544S398000, C544S399000, C544S400000, C544S402000, C546S021000, C546S229000, C546S230000, C546S231000, C560S013000
Reexamination Certificate
active
07074820
ABSTRACT:
There is provided compounds of formula I,wherein R1, R2, R3, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
REFERENCES:
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 5561146 (1996-10-01), Kim et al.
patent: 5583146 (1996-12-01), Kimball et al.
patent: 5602253 (1997-02-01), Antonsson et al.
patent: 5614499 (1997-03-01), Bylund et al.
patent: 5629324 (1997-05-01), Vacca et al.
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5723444 (1998-03-01), Antonsson et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5741792 (1998-04-01), Kimball et al.
patent: 5741799 (1998-04-01), Kimball et al.
patent: 5744487 (1998-04-01), Ohshima et al.
patent: 5780631 (1998-07-01), Antonsson et al.
patent: 5783563 (1998-07-01), Antonsson et al.
patent: 5792769 (1998-08-01), Lu et al.
patent: 6034127 (2000-03-01), Lu et al.
patent: 6133315 (2000-10-01), Lu et al.
patent: 6221898 (2001-04-01), Antonsson
patent: 6281206 (2001-08-01), Lu et al.
patent: 6285302 (2001-09-01), McClellan
patent: 2001/0025041 (2001-09-01), Lu et al.
patent: 0 185 390 (1986-06-01), None
patent: 0 195 212 (1986-09-01), None
patent: 0 293 881 (1988-12-01), None
patent: 0 362 002 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 530 167 (1993-03-01), None
patent: 0 542 525 (1993-05-01), None
patent: 0 559 046 (1993-09-01), None
patent: 0 601 459 (1994-06-01), None
patent: 0 623 596 (1994-11-01), None
patent: 0 641 779 (1995-03-01), None
patent: 0 648 780 (1995-04-01), None
patent: 0 669 317 (1995-08-01), None
patent: 686 642 (1995-12-01), None
patent: 93/11152 (1993-06-01), None
patent: 93/16038 (1993-08-01), None
patent: 93/18060 (1993-09-01), None
patent: 94/20467 (1994-09-01), None
patent: 94/29336 (1994-12-01), None
patent: 95/23609 (1995-09-01), None
patent: 95/35309 (1995-12-01), None
patent: 96/03374 (1996-02-01), None
patent: 96/06832 (1996-03-01), None
patent: 96/06849 (1996-03-01), None
patent: 96/16940 (1996-06-01), None
patent: 96/25426 (1996-08-01), None
patent: 96/32110 (1996-10-01), None
patent: 96/37482 (1996-11-01), None
patent: 97/11693 (1997-03-01), None
patent: 97/02284 (1997-07-01), None
patent: 97/23499 (1997-07-01), None
patent: 97/24135 (1997-07-01), None
patent: 97/47299 (1997-12-01), None
patent: 98/01422 (1998-01-01), None
patent: 98/06740 (1998-02-01), None
patent: 98/06741 (1998-02-01), None
Blomback et al, “Synthetic Peptides with Anticoagulant . . . ,” Scand. J. clin. Lab. Invest. Suppl. 107, pp. 59-64 (1969).
Claeson, G., “Synthetic peptides and peptidomimetics as substrates . . . ,” Blood Coagulation and Fibrinolysis, vol. 5, pp. 411-436 (1994).
von der Saal et al, “Derivatives of 4-Amino-Pyridine As . . . ,” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 10, pp. 1283-1288 (1997).
AstraZeneca AB
Barts Samuel
Nixon & Vanderhye
LandOfFree
Amidino derivatives and their use as thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidino derivatives and their use as thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidino derivatives and their use as thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587536